Celestica: One Of The Best Ways To Play The AI Infrastructure Buildout

Celestica's $1.0B 2026 CapEx plan is intended to fund capacity for visible AI-driven demand; management also raised revenue and adjusted EPS guidance. Management guided for 50% growth in CCS, which accounted for 74% of FY25 revenue, supporting the view that demand—not weak AI uptake—is the main risk. The market reaction in Q4 2025 appears overblown given the stronger guidance and targeted capital deployment.

Analysis

Celestica’s capacity push reframes the competitive map: a focused EMS player that front-loads capital to serve hyperscaler-style demand can widen margins through higher utilization and captive supply relationships, while diversified EMS peers face tougher choices on where to allocate scarce capex. Expect upward pressure on specialist upstream vendors (precision PCB houses, high-current PSUs, thermal modules) and longer lead times that raise switching costs for OEMs once ramps are live.

The main structural risk is demand concentration and volatility: a single large customer pause or inventory correction would leave new capacity underutilized for multiple quarters, creating margin compression as depreciation and ramp costs hit the P&L. Near-term sentiment will move on quarterly order commentary (days–weeks), revenue recognition and build cadence (1–4 quarters), and true payback on factory investments (2+ years).

The market appears to discount execution optionality and the likely sequence of cash flows: prepayments, booked backlog, and margin expansion from scale are underappreciated, but so is the binary nature of hyperscaler spending. The asymmetric payoff favors a targeted, time-boxed exposure that captures upside from order momentum while limiting downside if hyperscaler budgets re-contract; monitor hyperscaler capex commentary, customer-specific disclosures, and incremental gross margin trends as primary catalysts.

Key Decisions for Investors

• Long CLS equity (6–12 month horizon): add on pullbacks into initial weakness with a 30–40% upside target and a 20% stop-loss. Rationale: capture re-rating as utilization improves; de-risk by trimming into outsized positive order prints.
• Long-dated call spread on CLS (18–24 months): buy LEAP calls and sell a higher strike to fund premium (aim for 2:1 reward:risk). Use this to express leveraged, but capped, upside to the execution story while limiting theta decay risk.
• Pair trade — long CLS / short FLEX (equal notional, 6–12 months): expect CLS to outgrow/outspecialize FLEX on hyperscaler-focused builds. Target CLS relative outperformance of 20–30%; cut pair if order cadence converges or FLEX announces hyperscaler wins.
• Event hedge: if you hold CLS into the next quarterly report, buy OTM put protection sized to limit downside to ~15–20% for 30–90 days; catalyst risk around order commentary is high and protection is cheap relative to potential binary drawdowns.